Word

PORTON BIOPHARMA

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2017

Serial Number

79179755

Registration Number

5293334

Registration Date

Tuesday, September 26, 2017

Mark Type

4000

Filing Date

Friday, September 4, 2015

Published for Opposition

Tuesday, July 11, 2017

Trademark Owner History

PORTON BIOPHARMA LIMITED - Original Registrant

Classifications

41 Education, namely, providing conferences, seminars, workshops, training, and exhibitions in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals and their development and manufacture, and the distribution of course materials in connection therewith; arrangement of conferences for educational purposes; advice relating to medical training; advisory services relating to training; advisory services relating to education; arranging and conducting of workshops in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting instructional courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; conducting of educational seminars relating to medical matters; training courses relating to medicine; training courses relating to science; medical education services, namely, providing continuing medical education courses; medical training and teaching; organisation of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; publication of books; writing of texts other than publicity texts; providing continuing dental education courses; providing continuing medical education courses; provision of educational information about medical education; provision of training in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of training courses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; provision of on-line electronic publications not downloadable from the Internet in the nature of newsletters, articles, e-books, and white papers in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; production of video-tapes for corporate use in corporate educational training; professional consultancy relating to education; publication of educational material in the nature of textbooks in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for medical visitors in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services for nurses in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals; training services relating to health and safety; arranging and conducting of workshops relating to biologics; arranging and conducting of workshops relating to biopharmaceuticals; arranging and conducting training relating to biologics; arranging and conducting training relating to biopharmaceuticals; arrangement of workshops for educational purposes in the fields of pharmacy, medicine, biology, health and safety, biopharmaceuticals

5 Pharmaceutical preparations, namely, biologics and biopharmaceuticals in the form of vaccines, blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue used to protect against infectious disease and to treat cancers, rheumatoid diseases and disorders, skin diseases and disorders, immune system diseases and disorders, anemia and diseases of the blood, gastrointestinal diseases and disorders, and neurological diseases and disorders; sanitary preparations for medical purposes; plasters for medical purposes as materials for dressings; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical preparations and substances in the nature of vaccines and blood products in the nature of red blood cells, platelets, blood plasma, and blood plasma derivatives, namely, albumin, immunoglobulins and immunomodulatory factors, therapeutic proteins, gene therapy products, namely, pharmaceutical preparations for gene delivery and gene transfer for the treatment of cancers and diseases affecting the immune system, and living tissue; injectable pharmaceutical compositions and preparations comprising compounds having asparaginase activity for treatment of leukaemia; pharmaceutical compositions and preparations for the treatment of leukaemia and malignant diseases in the blood forming organs

Color is not claimed as a feature of the mark.
"BIOPHARMA"

Trademark Events

Sep 26, 2022

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Jan 26, 2018

Final Decision Transaction Processed By Ib

Dec 27, 2017

Final Disposition Notice Sent To Ib

Dec 27, 2017

Final Disposition Processed

Dec 26, 2017

Final Disposition Notice Created, To Be Sent To Ib

Sep 26, 2017

Registered-Principal Register

Jul 11, 2017

Official Gazette Publication Confirmation E-Mailed

Jul 11, 2017

Published For Opposition

Jul 8, 2017

Notification Processed By Ib

Jun 21, 2017

Notification Of Possible Opposition Sent To Ib

Jun 21, 2017

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Jun 21, 2017

Notification Of Notice Of Publication E-Mailed

Jun 5, 2017

Electronic Record Review Complete

Jun 2, 2017

On Hold - Electronic Record Review Required

May 23, 2017

Approved For Pub - Principal Register

May 5, 2017

Assigned To Examiner

May 3, 2017

Examiner's Amendment Entered

May 3, 2017

Notification Of Examiners Amendment E-Mailed

May 3, 2017

Examiners Amendment E-Mailed

May 3, 2017

Examiners Amendment -Written

Apr 18, 2017

Notification Of Subsequent Final Emailed

Apr 18, 2017

Continuation Of Final Refusal E-Mailed

Apr 18, 2017

Action Continuing A Final - Completed

Feb 27, 2017

Attorney Review Completed

Feb 27, 2017

Teas Request For Reconsideration Received

Feb 7, 2017

Correction From Ib Entered - Attorney Review Required

Dec 23, 2016

Correction Transaction Received From Ib

Sep 2, 2016

Notification Of Final Refusal Emailed

Sep 2, 2016

Final Refusal E-Mailed

Sep 2, 2016

Final Refusal Written

Aug 12, 2016

Teas/Email Correspondence Entered

Aug 12, 2016

Correspondence Received In Law Office

Jul 29, 2016

Assigned To Lie

Jul 25, 2016

Teas Response To Office Action Received

Feb 13, 2016

Refusal Processed By Ib

Jan 25, 2016

Non-Final Action Mailed - Refusal Sent To Ib

Jan 25, 2016

Refusal Processed By Mpu

Jan 22, 2016

Non-Final Action (Ib Refusal) Prepared For Review

Jan 21, 2016

Non-Final Action Written

Jan 19, 2016

Assigned To Examiner

Jan 12, 2016

Application Filing Receipt Mailed

Jan 7, 2016

Assigned To Examiner

Jan 7, 2016

New Application Office Supplied Data Entered In Tram

Jan 6, 2016

Limitation From Original Application Entered

Jan 3, 2016

Sn Assigned For Sect 66a Appl From Ib